Product/Service Type: eHealth Market Industry: Computer Systems Design Services Barnes Reports' Global Manufacturing & Makets report series provide estimates of the size and characteristics of the largest equipment, materials and consumables by manufacturing industries in the largest 140 global countries. These estimates are produced by a proprietary economic model that is based on a number of sources and factors

Product/Service Type: Eubiotics Industry: Medical Laboratories Barnes Reports' Global Manufacturing & Makets report series provide estimates of the size and characteristics of the largest equipment, materials and consumables by manufacturing industries in the largest 140 global countries. These estimates are produced by a proprietary economic model that is based on a number of sources and factors

Product/Service Type: Eubiotics Industry: Medical Laboratories Barnes Reports' Global Manufacturing & Makets report series provide estimates of the size and characteristics of the largest equipment, materials and consumables by manufacturing industries in the largest 140 global countries. These estimates are produced by a proprietary economic model that is based on a number of sources and factors

Material Type: Flea and tick insecticides, nonaerosol Industry: Pesticide and other agricultural chemical manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

Material Type: Oxytocics Industry: Pharmaceutical and medicine manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

Material Type: Parasympathomimetic cholinergic drugs Industry: Pharmaceutical and medicine manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

Material Type: Hemorrhoidal preparations Industry: Pharmaceutical and medicine manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

Material Type: Other anti-infective agents Industry: Pharmaceutical and medicine manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

23Q2全部公募基金占比11.70%，环比+0.04pp；剔除主动医药基金占比8.54%，环比+0.30pp；再剔 除指数基金占比7.60%，环比+0.18pp；申万医药板块市值占比为7.47%，环比-0.42pp；

国家医保局发布《2022 年全国医疗保障事业发展统计公报》，2022年，全国基本医疗保险 (含生育保险) 基金总收入 30,922.17 亿元比上年增长 7.6%: 全国基本医疗保险 (含生育保险) 基金总支出24.597.24 亿元，比上年增长 2.3%。在集采控费的背景下，医保基金仍保持增长态势。医保局正式发布《谈判药品续约规则》及《非独家药品竞价规则》，和征求意见稿基本一致，创新药支付端边际明显改善。2023 年半年报披露在即，我们持续关注创新药板块业绩超预期的企业。